Baker Hughes (Canada)

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Sue S. Yom, Pedro A. Torres‐Saavedra, Jimmy J. Caudell et al. · Journal of Clinical Oncology · 2021 · 344 citations · Full text

Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

Nils Kroeger, Wanling Xie, Jae‐Lyn Lee et al. · Cancer · 2013 · 231 citations · Full text

Demulsification Mechanism of Asphaltene-Stabilized Water-in-Oil Emulsions by a Polymeric Ethylene Oxide–Propylene Oxide Demulsifier

Erica Pensini, David Harbottle, Fan Yang et al. · Energy & Fuels · 2014 · 216 citations

Demulsification Mechanism, Engineering, Chemistry +16

Validation of the Risk Model: High-Risk Classification and Tumor Pattern of Invasion Predict Outcome for Patients with Low-Stage Oral Cavity Squamous Cell Carcinoma

Yufeng Li, Shuting Bai, William R. Carroll et al. · Head and Neck Pathology · 2012 · 189 citations · Full text

Risk Model, Medicine, Epidemiology Of Cancer +8

Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer

Margot J. Burnell, Mark N. Levine, Judith‐Anne W. Chapman et al. · Journal of Clinical Oncology · 2009 · 152 citations · Full text

Surgical Oncology, Breast Oncology, Cancer Management +18